Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
23.68
-0.16 (-0.67%)
Apr 16, 2026, 1:34 PM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Biotechnology
84.68M10.65M7.76M657.00K
Biotechnology Growth
695.15%37.31%1080.52%-
Total
84.68M10.65M7.76M657.00K
Total Growth
695.15%37.31%1080.52%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
84.68M10.65M7.76M657.00K
United States Growth
695.15%37.31%1080.52%-
Total
84.68M10.65M7.76M657.00K
Total Growth
695.15%37.31%1080.52%-
Source: S&P Global Market Intelligence.